Mind-Body Pain Management for Cystic Fibrosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new way to manage pain for adults with cystic fibrosis (CF) using a mind-body approach instead of medication. Participants will engage in a three-session program conducted through telehealth, focusing on coping strategies and empowerment. This program is called Pain Acknowledgment Coping and Empowerment in CF (PACE CF). The study will assess whether this approach reduces pain's impact on daily life and improves overall well-being. Suitable candidates for this trial are English-speaking adults with CF who have experienced moderate pain for at least one month. As an unphased trial, this study offers participants the opportunity to contribute to innovative pain management strategies and potentially enhance their quality of life.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. In fact, it encourages a multi-component approach to pain management, which can include your existing pain medications.
What prior data suggests that the PACE CF intervention is safe for adults with cystic fibrosis?
Research shows that mind-body treatments like PACE CF are usually easy for people to handle. Since PACE CF doesn't involve medication, it carries a lower risk of side effects compared to drug treatments. Participants in similar programs often report few or no negative effects, suggesting that PACE CF should be safe for adults with cystic fibrosis. However, because this program is new, researchers are still collecting direct data on its safety in humans. The goal is to determine how effectively it manages pain without causing harm.12345
Why are researchers excited about this trial?
Researchers are excited about the PACE CF program because it offers a fresh approach to pain management in cystic fibrosis, focusing on mind-body techniques rather than medication. While traditional treatments often involve painkillers or physical therapies, PACE CF empowers patients through psychological strategies, helping them acknowledge and cope with pain in a healthier way. This approach could potentially reduce the reliance on medications, leading to fewer side effects and a more holistic management of pain.
What evidence suggests that the PACE CF intervention is effective for managing pain in cystic fibrosis?
Research has shown that mind-body techniques can help manage pain in people with cystic fibrosis (CF). In this trial, participants will engage in the PACE CF program, a new method designed specifically for adults with CF. Early results suggest that these techniques can lessen pain and improve coping. While specific data on PACE CF is still being gathered, early signs are encouraging for effective pain management. This method focuses on recognizing pain and equipping patients with tools to handle it better, potentially improving their quality of life and reducing the need for pain medication.12346
Who Is on the Research Team?
Amanda Bruce, PhD
Principal Investigator
University of Kansas Medical Center
Are You a Good Fit for This Trial?
This trial is for adults with cystic fibrosis who experience pain. Participants must be able to attend three telehealth sessions and may be at home or hospitalized. Specific eligibility criteria are not provided, but typically include factors like age range, disease severity, and ability to comply with study requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete a 3-session mind-body pain management program (PACE CF) via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of quality of life and pain management
What Are the Treatments Tested in This Trial?
Interventions
- Pain Acknowledgment Coping and Empowerment in CF (PACE CF)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
University of Kansas Medical Center
Collaborator